L-G again rejects Delhi Govt's panel to probe deaths due to oxygen shortage
Darpan News Desk IANS, 20 Aug, 2021 01:17 PM
New Delhi, Aug 20 (IANS) Delhi Lt Governor Anil Baijal has again rejected the Delhi Government's request to set up a panel to investigate the deaths due to alleged oxygen shortage during the second wave of the Covid pandemic, said Deputy Chief Minister Manish Sisodia on Friday.
Sisodia, who is also the nodal minister for Covid management in the national capital, stated that no one can deny that Delhi grappled with an oxygen shortage during the peak of the second wave of the Covid pandemic (April-May) and several people died due to oxygen shortage.
"The Central Government has again rejected the proposal to form a committee to investigate the deaths due to lack of oxygen," Sisodia tweeted.
He added, "On the one hand, they (Centre) pretend to ask the states for the figures of deaths due to O2 deficiency, on the other hand, they stop the inquiry committee. After all, what does the Central government wants to hide."
The Delhi Government had again sent a file to the L-G office seeking it's approval to form a committee to investigate deaths due to an oxygen crisis in the national capital.
The Delhi Government had formed a four-member panel in June this year to look into the deaths due to shortage of oxygen. However, the committee was rejected by the L-G.
Simone Burns, an Irish lawyer, spat at a flight attendant during her foul-mouthed racist tirade after she was refused alcohol on the flight in November last year.
The Special Investigation Team (SIT) formed by the Punjab Government to probe the Neha Shoree murder case has found the name and number of the killer saved on her phone.
An Indian journal publisher and his companies have been fined over USD 50 million in the US for making “deceptive claims” to academics about the nature of their work and taking millions of dollars from aspiring researchers and writers.
The Bench, also comprising Justices Deepak Gupta and Sanjiv Khanna, has now fixed the contempt petition of the Japanese firms against the former Ranbaxy promoters for hearing on April 11.
